How many employees are at Sumitomo?
Sun Pharmaceutical Industries Limited supports a robust global team of more than forty-three thousand employees operating within the international pharmaceutical manufacturing and healthcare sectors. As a leading specialty generic pharmaceutical enterprise, the company coordinates an extensive operational footprint comprising multiple research and development centers and manufacturing plants across India, the United States, and various global markets. Its workforce features a high concentration of pharmaceutical research scientists, clinical trial specialists, chemical process engineers, regulatory compliance officers, and medical sales representatives dedicated to delivering accessible medicines.
Related FAQs
Sumitomo Corporation and its major affiliated corporate entities distribute regular cash dividend payments to their eligible equity investors, reflecting a strong commitment to shareholder value return frameworks.
MKS Instruments holds a substantial market valuation reflecting its standing as a prominent global provider of instruments, subsystems, and process control solutions for advanced manufacturing markets.
As of the close of the trading session on July 24, 2026, the stock price for Sun Communities Inc. (SUI) was $121.83 per share.